1305-0013 Trial Investigators 2022, ' Trial of a Preferential Phosphodiesterase 4B Inhibitor for Idiopathic Pulmonary Fibrosis ', New England Journal of Medicine, vol. 386, no. 23, pp. 2178-2187 . https://doi.org/10.1056/NEJMoa2201737 New England Journal of Medicine, 386(23), 2178-2187. Massachussetts Medical Society
Allen, R, Oldman, J, Jenkins, D A, Leavy, O, Flores, C, Noth, I, Jenkins, R G & Wain, L 2022, ' Longitudinal lung function and gas transfer in individuals with idiopathic pulmonary fibrosis: a genome-wide association study ', The Lancet Respiratory Medicine . https://doi.org/10.1016/S2213-2600(22)00251-X